ABBOTT LABORATORIES — Director's Dealing 2005

Jan 26, 2005

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2004-12-21

Reporting Person: Landgraf John C (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2004-12-21	Common Shares without par value	G	5588	—	Disposed	37068	Direct
2005-01-21	Common Shares without par value	M	9221	$18.3919	Acquired	46289	Direct
2005-01-21	Common Shares without par value	F	3706	$45.75	Disposed	42583	Direct
2005-01-21	Common Shares without par value	G	5515	—	Disposed	37068	Direct
2004-12-21	Common Shares without par value	G	5588	—	Acquired	33035	Indirect
2005-01-21	Common Shares without par value	G	5515	—	Acquired	38550	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2005-01-21	Option (right to buy)	$18.3919	D	9221	Disposed	2005-04-27	Common Shares (9221)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares without par value	14414	Indirect
Common Shares without par value	833	Indirect

Footnotes

F1: Held in the Anne Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees of the trust. The trust is revocable by his spouse. 27,477 of the shares held by the trust were previously incorrectly reported as being directly owned by the reporting person.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of 01-21-2005.

F3: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11.

F4: Reporting person disclaims beneficial ownership of all securities held by son.